Valeria Belleudi

ORCID: 0000-0002-8286-443X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Biosimilars and Bioanalytical Methods
  • Pregnancy and Medication Impact
  • Renal Transplantation Outcomes and Treatments
  • Pharmaceutical Economics and Policy
  • SARS-CoV-2 and COVID-19 Research
  • Chronic Disease Management Strategies
  • Asthma and respiratory diseases
  • Pregnancy and preeclampsia studies
  • Medication Adherence and Compliance
  • Neonatal Respiratory Health Research
  • Organ Transplantation Techniques and Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Emergency and Acute Care Studies
  • Respiratory viral infections research
  • COVID-19 Clinical Research Studies
  • Pneumonia and Respiratory Infections
  • Healthcare Systems and Practices
  • Pharmacovigilance and Adverse Drug Reactions
  • Respiratory Support and Mechanisms
  • Substance Abuse Treatment and Outcomes
  • Pharmaceutical studies and practices
  • Inflammatory Bowel Disease
  • Rheumatoid Arthritis Research and Therapies

Azienda Sanitaria Locale Roma 3
2006-2024

Servizio Sanitario Nazionale
2012-2024

ASL Roma
2007-2024

Agenzia Regionale Parchi
2010-2024

Regional Health
2015-2023

Regione Lazio
2010-2023

Regione Campania
2018-2022

Ferro (United States)
2016

University of Florida
2016

Columbus Oncology and Hematology Associates
2016

ABSTRACT Background Specialist drug treatment is critical to overdose prevention; methadone maintenance effective, but we lack evidence for other modalities. We evaluate the impact of a range treatments opiate dependence on mortality. Methods Prospective cohort study 10 454 heroin users entering 1998–2001 in Italy followed‐up 208 person‐years and 2914 out treatment. Standardized overall mortality ratios (SMR) estimate excess risk compared general population. Cox models compare hazard ratio...

10.1111/j.1360-0443.2007.02025.x article EN Addiction 2007-11-19

Little is known about the short-term effects of ultrafine particles.We evaluated effect particulate matter with an aerodynamic diameter <or=10 microm (PM10), <or=2.5 (PM2.5), and particles on emergency hospital admissions in Rome 2001-2005. We studied residents aged >or=35 years hospitalized for acute coronary syndrome, heart failure, lower respiratory tract infections, chronic obstructive pulmonary disease (COPD). Information was available factors indicating vulnerability, such as age...

10.1097/ede.0b013e3181d5c021 article EN Epidemiology 2010-03-23

Background Myocarditis and pericarditis following the Coronavirus Disease 2019 (COVID-19) mRNA vaccines administration have been reported, but their frequency is still uncertain in younger population. This study investigated association between Severe Acute Respiratory Syndrome 2 (SARS-CoV-2) vaccines, BNT162b2, mRNA-1273 myocarditis/pericarditis population of vaccinated persons aged 12 to 39 years Italy. Methods findings We conducted a self-controlled case series (SCCS) using national data...

10.1371/journal.pmed.1004056 article EN cc-by PLoS Medicine 2022-07-28

To date, no population-based studies have specifically explored the external validity of pivotal randomized clinical trials (RCTs) biologics simultaneously for a broad spectrum immuno-mediated inflammatory diseases (IMIDs). The aims this study were, firstly, to compare patients' characteristics and median treatment duration approved IMIDs between RCTs' real-world setting (RW); secondly, assess extent biologic users treated in that would not been eligible inclusion into RCT each indication...

10.1016/j.phrs.2024.107074 article EN cc-by Pharmacological Research 2024-01-21

Purpose: This research aimed to develop and validate a META-algorithm combining individual immune-mediated inflammatory disease (IMID)-specific algorithms identify the exact IMID indications for incident biological drug users from claims data within context of Italian VALORE project. Methods Patients: All subjects with at least one dispensing TNF-alpha inhibitors, anti-interleukin agents, selective immunosuppressants approved IMIDs were identified databases Latium region in Italy...

10.2147/clep.s445120 article EN cc-by-nc Clinical Epidemiology 2024-06-01

Limited real-world data on biological drug use in older patients with immune-mediated inflammatory diseases (IMIDs) exist despite these drugs carrying serious risks this population. We aimed to describe the frequency and persistence of (≥ 65 years) IMID, including bowel (IBDs), psoriatic arthritis/psoriasis, rheumatoid arthritis (RA), ankylosing spondylitis, a large Italian A retrospective cohort study using VALORE distributed claims database network from 13 regions years 2010-2022 was...

10.1007/s40259-025-00716-2 article EN cc-by-nc BioDrugs 2025-04-03
Gianluca Trifirò Valentina Isgrò Ylenia Ingrasciotta Valentina Ientile Luca L’Abbate and 95 more Saveria Serena Foti Valeria Belleudi Francesca Romana Poggi Andrea Fontana Ugo Moretti Riccardo Lora Alberto Sabaini Ilenia Senesi Carla Sorrentino Maria R. Puzo Angela Padula Mariano Fusco Roberta Giordana Valentina Solfrini Aurora Puccini Paola Rossi Stefania Del Zotto Olivia Leoni Martina Zanforlini Domenica Ancona Vito Bavaro Donatella Garau Stefano Ledda Salvatore Scondotto Alessandra Allotta Marco Tuccori Rosa Gini Giampaolo Bucaneve David Franchini Anna Cavazzana Valeria Biasi Stefania Spila Alegiani Marco Massari Gianluca Trifirò Ugo Moretti Riccardo Lora Alberto Sabaini Valentina Isgrò Ylenia Ingrasciotta Valentina Ientile Luca L’Abbate Saveria Serena Foti Stefania Spila Alegiani Valeria Belleudi Francesca Romana Poggi Andrea Fontana Marco Massari Ilaria Andretta Matilde Tanaglia Ilenia Senesi Carla Sorrentino Maria Rosalia Puzo Angela Padula Antonio Carriero S. Sassano Caterina De Sarro Simona Mirarchi Caterina Palleria Caterina De Sarro Mariano Fusco Roberta Giordana Marianna Balestrieri Stefania Rostan Annalisa Capuano Francesca Futura Bernardi Ugo Trama Alessandro Russo Maria Grazia Fumo Valeria Belleudi Francesca Romana Poggi Antonio Addis Felice Musicco Valentina Solfrini Ester Sapigni Aurora Puccini Ilaria Mazzetti Debora Podetti Anna Maria Potenza Victoria Nikitina Rita Ricciardelli Nazanin Mogheiseh Silvia Croce Paola Rossi A. Pettinelli Stefania Del Zotto Lucian Ejlli Olivia Leoni Ida Fortino Michele Ercolanoni Arianna Mazzone Andrea Angelo Nisic Simone Schiatti Monica Ludergnani Martina Zanforlini Mauro Mancini

Biological drugs have improved the management of immune-mediated inflammatory diseases (IMIDs) despite being associated with important safety issues such as immunogenicity, infections, and malignancies in real-world settings.The aim this study was to explore potential a large Italian multi-database distributed network for use postmarketing surveillance biological drugs, including biosimilars, patients IMID.A retrospective cohort conducted using 13 regional claims databases during 2010-2019....

10.1007/s40259-021-00498-3 article EN cc-by-nc BioDrugs 2021-10-12

In countries where the National Health Service provides universal health coverage, socioeconomic position should not influence quality of care. We examined whether plays a role in short-term mortality and waiting time for surgery after hip fracture.Retrospective cohort study.and participants From Hospital Information System database, we selected all patients, aged at least 65 years admitted to acute care hospitals Rome fracture between 1 January 2006 30 November 2007. The each individual was...

10.1093/intqhc/mzp046 article EN International Journal for Quality in Health Care 2009-10-19

Adherence to evidence-based drug therapy after acute myocardial infarction has increased over the last decades, but is still unsatisfactory. Our objectives are set out analyse patterns of (AMI), and evaluating socio-demographic differences.A cohort 3920 AMI patients discharged from hospital in Rome (2006-2007) was selected. Drugs claimed during 12 months discharge were retrieved. Drug utilization defined as density use (boxes claimed/individual follow-up; chronic = 6+ boxes/365 days)...

10.1111/j.1365-2710.2010.01242.x article EN Journal of Clinical Pharmacy and Therapeutics 2011-02-06

Importance: Since the beginning of Coronavirus Disease-19 (COVID-19) pandemic, Severe Acute Respiratory Syndrome-CoV-2 (SARS-CoV-2) infection has been a serious challenge for immune-compromised patients with immune-mediated inflammatory diseases (IMIDs). Objective: Our aim was to investigate impact COVID-19 in terms risks infection, hospitalization and mortality cohort rheumatoid arthritis (RA), psoriasis (PSO) or bowel disease (IBD). Furthermore, we studied SARS-CoV-2 on prescribed drug...

10.3390/jcm10112388 article EN Journal of Clinical Medicine 2021-05-28

Background Recently published studies have reported association of COVID-19 vaccine ChAdOx1-S (Vaxzevria) with Guillain Barré Syndrome (GBS). Less is known about the safety other vaccines respect to GBS outcome. This study investigated in more than 15 million persons aged ≥12 years Italy. Methods Study population was all individuals who received at least one dose vaccines, admitted emergency care/hospital for from 27 December 2020–30 September 2021 Identification cases and receipt mRNA-1273...

10.1371/journal.pone.0290879 article EN cc-by PLoS ONE 2024-01-19

Abstract Purpose Whether inhaled medications improve long‐term survival in Chronic Obstructive Pulmonary Disease (COPD) is an open question. The purpose of this study to assess the impact adherence drug use on 5‐year COPD. Methods A population‐based cohort three Italian regions was conducted using healthcare linked datasets (hospitalization, mortality, drugs). Individuals (45+ years) discharged after COPD exacerbation 2006–2009 were enrolled. Inhaled daily during follow‐up determined through...

10.1002/pds.4059 article EN cc-by-nc-nd Pharmacoepidemiology and Drug Safety 2016-07-11

The goal of post-transplant immunosuppressive drug therapy is to prevent organ rejection while minimizing toxicities. In clinical practice, a multidrug approach commonly used and involves drugs with different mechanisms action, including calcineurin inhibitors (CNI) (tacrolimus or cyclosporine), antimetabolite (antimet) (mycophenolate azathioprine), mechanistic target rapamycin (mTOR) (sirolimus everolimus), and/or steroids. Although evidence based on several randomized trials available, the...

10.3389/fphar.2022.959267 article EN cc-by Frontiers in Pharmacology 2022-09-15

Abstract Background Socioeconomic status could affect the demand for hospital care. The aim of present study was to assess role age, socioeconomic and comorbidity on acute admissions among elderly. Methods We retrospectively examined discharge abstracts data care residents in Rome aged 75 or more years period 1997–2000. used Hospital Information System Rome, Tax Register, Population Register socio-economic data. rate hospitalization, modified Charlson's index comorbidity, level income census...

10.1186/1471-2458-7-227 article EN cc-by BMC Public Health 2007-08-31

ABSTRACT Purpose There are some methodological concerns regarding results from observational studies about the effectiveness of evidence‐based (EB) drug therapy in secondary prevention after myocardial infarction. The present study used a nested case–control approach to address these major limitations. Methods A cohort 6880 patients discharged hospital acute infarction (AMI) 2006–2007 was enrolled and followed‐up throughout 2009. Exposure defined as adherence each terms proportion days...

10.1002/pds.3430 article EN other-oa Pharmacoepidemiology and Drug Safety 2013-03-26

To evaluate the benefit/risk profile of epoetin α biosimilar with erythropoiesis-stimulating agents (ESAs) originators when administered to naïve patients from clinical practice.

10.1136/bmjopen-2016-011637 article EN cc-by-nc BMJ Open 2017-03-01

Real-world data on the comparative effectiveness and safety of switching among different epoetins (including originators biosimilars) are limited. In light current debate about interchangeability, prescribers, some patient groups decision makers calling for additional post-marketing evidence clinical effects between originator biosimilar in chronic kidney disease (CKD) patients. The objective this study was to evaluate versus non-switching from originator/biosimilar epoetin alpha (ESA α) any...

10.1007/s40264-019-00845-y article EN cc-by-nc Drug Safety 2019-06-21

Maintenance immunosuppressive therapy used in kidney transplantation typically involves calcineurin inhibitors, such as tacrolimus or cyclosporine, combination with mycophenolate mechanistic target of rapamycin (mTORi) without corticosteroids. An Italian retrospective multicentre observational study was conducted to investigate the risk-benefit profile different regimens. We identified all subjects who underwent transplant between 2009 and 2019, using healthcare claims data. Patients on...

10.1371/journal.pone.0295205 article EN cc-by PLoS ONE 2024-01-02

Cases of appendicitis were identified in the pivotal randomized clinical trial on BNT162b2 mRNA vaccine and reported from coronavirus disease 2019 (COVID-19) pharmacovigilance systems. Three cohort studies two self-controlled case series (SCCS) evaluating association between vaccines discordant results. To address this uncertainty, present study examines a large population, with SCCS design, (BNT162b2 mRNA-1273) and, for first time, viral vector (ChAdOx1-S Ad26.COV2-S) COVID-19 acute appendicitis.

10.1007/s40264-024-01462-0 article EN cc-by-nc Drug Safety 2024-07-27

To ascertain if the use of hydroxychloroquine(HCQ)/cloroquine(CLQ) and other conventional DMARDs (cDMARDs) rheumatic diseases per se may be associated with COVID-19-related risk hospitalization mortality. This case-control study nested within a cohort cDMARD users was conducted in Lombardy, Veneto, Tuscany Lazio regions Reggio Emilia province. Claims databases were linked to COVID-19 surveillance registries. The outcomes estimated using multivariate conditional logistic regression analysis...

10.1093/rheumatology/keab348 article EN other-oa Lara D. Veeken 2021-04-13

To investigate the association of 2019-2020 influenza vaccine with prognosis patients positive for SARS-CoV-2A, a large multi-database cohort study was conducted in four Italian regions (i.e., Lazio, Lombardy, Veneto, and Tuscany) Reggio Emilia province (Emilia-Romagna). More than 21 million adults were residing area (42% population). We included 115,945 COVID-19 cases diagnosed during first wave pandemic (February-May, 2020); 34.6% these had been vaccinated against influenza. Three outcomes...

10.3390/vaccines9070716 article EN cc-by Vaccines 2021-07-01

Background In immunosuppression after transplantation, several multi-drug approaches are used, involving calcineurin inhibitors ( CNI: tacrolimus-TAC or cyclosporine-CsA ), antimetabolites antiMs mammalian target of rapamycin mTORis and corticosteroids. However, data on immunosuppressive therapy by organ its space–time variability lacking. Methods An Italian multicentre observational cohort study was conducted using health information systems. Patients with incident transplant during...

10.3389/frtra.2022.1060621 article EN cc-by Frontiers in Transplantation 2023-01-16
Coming Soon ...